Back
ANI Pharmaceuticals 10K Form
Sell
42
ANIP
ANI Pharmaceuticals
Last Price:
$64.37
Seasonality Move:
12.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
| 2023-11-08 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
| 2023-08-09 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
| 2023-05-08 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
| 2022-11-09 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
| 2022-08-08 | 10Q | ANIP/ANI Pharmaceuticals Quarterly |
Receive ANIP News And Ratings
See the #1 stock for the next 7 days that we like better than ANIP
ANIP Financial Statistics
Sales & Book Value
| Annual Sales: | $614.4M |
|---|---|
| Cash Flow: | $13.4M |
| Price / Cash Flow: | 26.74 |
| Annual Sales: | $19.12 |
| Price / Book: | 3.5 |
Profitability
| EPS (TTM): | -1.14000 |
|---|---|
| Net Income (TTM): | $-18.5M |
| Gross Margin: | $364.2M |
| Return on Equity: | -4.07% |
| Return on Assets: | -1.74% |
ANI Pharmaceuticals Earnings Forecast
Key ANI Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 17 years for ANIP is 59.27%.
-
The Selling, General & Administrative Expenses for ANIP have been equal to 40.63% of Gross Profit Margin.
-
The Research & Development expenses have been 7.26% of Revenue.
-
The Net Earning history of ANIP is -3.01% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 12 years.
ANI Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ANIP |
| CUSIP: | 00182C |
| Website: | anipharmaceuticals.com |
Debt
| Debt-to-Equity Ratio: | 1.46 |
|---|---|
| Current Ratio: | 2.72 |
| Quick Ratio: | 1.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 72.81 |
|---|---|
| Forward P/E Ratio: | 9.29 |
ANIP Technical Analysis vs Fundamental Analysis
Sell
42
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy or a Sell?
-
ANI Pharmaceuticals stock is rated a SellThe current ANI Pharmaceuticals [ANIP] share price is $64.87. The Score for ANIP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.